Lai LT - Search Results

1

Antitumor activity of actinonin in vitro and in vivo.

Xu Y, Lai LT, Gabrilove JL, Scheinberg DA. Xu Y, et al. Among authors: lai lt. Clin Cancer Res. 1998 Jan;4(1):171-6. Clin Cancer Res. 1998. PMID: 9516967

2

Interleukin-2 enhancement of cytotoxicity by humanized monoclonal antibody M195 (anti-CD33) in myelogenous leukemia.

Caron PC, Lai LT, Scheinberg DA. Caron PC, et al. Among authors: lai lt. Clin Cancer Res. 1995 Jan;1(1):63-70. Clin Cancer Res. 1995. PMID: 9815888

3

Vaccination of patients with chronic myelogenous leukemia with bcr-abl oncogene breakpoint fusion peptides generates specific immune responses.

Pinilla-Ibarz J, Cathcart K, Korontsvit T, Soignet S, Bocchia M, Caggiano J, Lai L, Jimenez J, Kolitz J, Scheinberg DA. Pinilla-Ibarz J, et al. Blood. 2000 Mar 1;95(5):1781-7. Blood. 2000. PMID: 10688838 Free article. Clinical Trial.

4

An alpha-particle emitting antibody ([213Bi]J591) for radioimmunotherapy of prostate cancer.

McDevitt MR, Barendswaard E, Ma D, Lai L, Curcio MJ, Sgouros G, Ballangrud AM, Yang WH, Finn RD, Pellegrini V, Geerlings MW Jr, Lee M, Brechbiel MW, Bander NH, Cordon-Cardo C, Scheinberg DA. McDevitt MR, et al. Cancer Res. 2000 Nov 1;60(21):6095-100. Cancer Res. 2000. PMID: 11085533

5

Radioimmunotherapy for model B cell malignancies using 90Y-labeled anti-CD19 and anti-CD20 monoclonal antibodies.

Ma D, McDevitt MR, Barendswaard E, Lai L, Curcio MJ, Pellegrini V, Brechbiel MW, Scheinberg DA. Ma D, et al. Leukemia. 2002 Jan;16(1):60-6. doi: 10.1038/sj.leu.2402320. Leukemia. 2002. PMID: 11840264

6

Tumor therapy with targeted atomic nanogenerators.

McDevitt MR, Ma D, Lai LT, Simon J, Borchardt P, Frank RK, Wu K, Pellegrini V, Curcio MJ, Miederer M, Bander NH, Scheinberg DA. McDevitt MR, et al. Among authors: lai lt. Science. 2001 Nov 16;294(5546):1537-40. doi: 10.1126/science.1064126. Science. 2001. PMID: 11711678

7

Potentiation of apoptosis by treatment with the protein kinase C-specific inhibitor safingol in mitomycin C-treated gastric cancer cells.

Schwartz GK, Haimovitz-Friedman A, Dhupar SK, Ehleiter D, Maslak P, Lai L, Loganzo F Jr, Kelsen DP, Fuks Z, Albino AP. Schwartz GK, et al. J Natl Cancer Inst. 1995 Sep 20;87(18):1394-9. doi: 10.1093/jnci/87.18.1394. J Natl Cancer Inst. 1995. PMID: 7658500

8

The mutational status of p53 protein in gastric and esophageal adenocarcinoma cell lines predicts sensitivity to chemotherapeutic agents.

Nabeya Y, Loganzo F Jr, Maslak P, Lai L, de Oliveira AR, Schwartz GK, Blundell ML, Altorki NK, Kelsen DP, Albino AP. Nabeya Y, et al. Int J Cancer. 1995 Feb 20;64(1):37-46. doi: 10.1002/ijc.2910640109. Int J Cancer. 1995. PMID: 7665247

9

Differences in skin flora between inpatients and chronically ill outpatients.

Larson EL, Cronquist AB, Whittier S, Lai L, Lyle CT, Della Latta P. Larson EL, et al. Heart Lung. 2000 Jul-Aug;29(4):298-305. doi: 10.1067/mhl.2000.108324. Heart Lung. 2000. PMID: 10900068 Free article.

10

Relationship between skin microbial counts and surgical site infection after neurosurgery.

Cronquist AB, Jakob K, Lai L, Della Latta P, Larson EL. Cronquist AB, et al. Clin Infect Dis. 2001 Oct 15;33(8):1302-8. doi: 10.1086/322661. Epub 2001 Sep 14. Clin Infect Dis. 2001. PMID: 11565069

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

93 results

Search Page

Filters